The fact that high glucose and/or diabetes-induced phosphorylation of ErbB3 and ErbB4 could also be blocked by Ang-(1–7), leads us to conclude that at least in the diabetic vasculature Ang-(1–7) acts as a pan-ErbB inhibitor at the level of receptor transactivation. Here, EGFR is linked to diabetes mellitus.